160
Participants
Start Date
May 28, 2025
Primary Completion Date
August 30, 2028
Study Completion Date
August 30, 2028
Multilevel Adherence Intervention
Participants enrolled in this adherence program will have individualized counseling sessions with their clinical pharmacists regarding their oral anticancer agent based on their risk-stratified monitoring category. Participants will be followed longitudinally and will receive tailored support.
RECRUITING
UNC Chapel Hill, Chapel Hill
National Cancer Institute (NCI)
NIH
UNC Lineberger Comprehensive Cancer Center
OTHER